Bronchioid is represented by patients who are female and nonsmoking, who have a superior survival outcome, and who present with well-differentiated, bronchioloalveolar morphology, early stage and EGFR mutated cancers [6], [8], [14], [16], [19], [21], [39]. This evidence concerns the gene EGFR and cancer.